Literature DB >> 1535072

Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.

E Hollander1, A McCarley.   

Abstract

BACKGROUND: Preclinical and clinical studies suggest that yohimbine facilitates sexual behavior and may be helpful in the treatment of male impotence. A single case report suggests that yohimbine may be used to treat the sexual side effects of clomipramine. This study evaluated yohimbine as a treatment for the sexual side effects caused by serotonin reuptake blockers.
METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or affective disorders who suffered sexual side effects after treatment with serotonin reuptake blockers were given yohimbine on a p.r.n. basis in an open clinical trial. Various doses of yohimbine were used to determine the ideal dose for each patient.
RESULTS: Five of the six patients experienced improved sexual functioning after taking yohimbine. One patient who failed to comply with yohimbine treatment had no therapeutic effects. Side effects of yohimbine included excessive sweating, increased anxiety, and a wound-up feeling in some patients.
CONCLUSION: The results of this study indicate that yohimbine may be an effective treatment for the sexual side effects caused by serotonin reuptake blockers. Future controlled studies are needed to further investigate the effectiveness and safety of yohimbine for this indication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535072

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Effectiveness of yohimbine in the treatment of erectile disorder: four meta-analytic integrations.

Authors:  M P Carey; B T Johnson
Journal:  Arch Sex Behav       Date:  1996-08

Review 2.  Delayed orgasm and anorgasmia.

Authors:  Lawrence C Jenkins; John P Mulhall
Journal:  Fertil Steril       Date:  2015-10-09       Impact factor: 7.329

3.  The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials.

Authors:  J Craig Nelson; Yili Lu Pritchett; Oleg Martynov; Jimmy Y Yu; Craig H Mallinckrodt; Michael J Detke
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

4.  Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial.

Authors:  Amirhossein Modabbernia; Hamid Sohrabi; Abbas-Ali Nasehi; Firoozeh Raisi; Sepideh Saroukhani; Amirhossein Jamshidi; Mina Tabrizi; Mandana Ashrafi; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2012-05-03       Impact factor: 4.530

Review 5.  Psychotropic drug-induced sexual function disorders: diagnosis, incidence and management.

Authors:  D O Clayton; W W Shen
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

6.  Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.

Authors:  Murad Atmaca; Sevda Korkmaz; Mehtap Topuz; Osman Mermi
Journal:  Psychiatry Investig       Date:  2010-11-20       Impact factor: 2.505

Review 7.  Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Nieves Prieto; Rubén de Alarcón; Nerea Casado-Espada; Javier de la Iglesia; Laura Montejo
Journal:  J Clin Med       Date:  2019-10-07       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.